Enterobacteria producing extended-spectrum β-lactamases and IMP-1 metallo-β-lactamases isolated from Brazilian hospitals

References

1. Arakawa Y., Shibata N., Shibayama K., Kurokawa H., Yagi T., Fujiwara H., Goto M. 2000; Convenient test for screening metallo- β -lactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microbiol 38:40–43
   [Google Scholar]
2. Cartelle M., del Mar Tomas M., Pertega S., Beceiro A., Dominguez M. A., Velasco D., Molina F., Villanueva R., Bou G. 2004; Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins. J Clin Microbiol 42:4242–4249 [CrossRef]
   [Google Scholar]
3. Deshpande L. M., Fritsche T. R., Jones R. N. 2004; Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 49:231–236 [CrossRef]
   [Google Scholar]
4. Grinbaum R. S., Adriano Neto A., Guimarães T. 7 other authors 2004; IMP-1-producing Klebsiella pneumoniae outbreak in a Brazilian teaching hospital. In Abstracts of the 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy Washington, DC: 30 October–2 November 2004p– 112 Washington, DC: American Society for Microbiology;
   [Google Scholar]
5. Kiffer C., Hsiung A., Oplustil C., Sampaio J., Sakagami E., Turner P., Mendes C. & The MYSTIC Brazil group 2003; 2005; Antimicrobial susceptibility of Gram-negative bacteria in Brazilian hospitals: the MYSTIC program Brazil 2003. Braz J Infect Dis 9:216–224
   [Google Scholar]
6. Lincopan N., McCulloch J. A., Reinert C., Cassettari V. C., Gales A. C., Mamizuka E. M. 2005; First isolation of metallo- β -lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil. J Clin Microbiol 43:516–519 [CrossRef]
   [Google Scholar]
7. Marra A. R., Wey S. B., Castelo A., Gales A. C., Cal R. G. R., do Carmo Filho J. R., Edmond M. B., Pereira C. A. P. 2006; Nosocomial bloodstream infections caused by Klebsiella pneumoniae : impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect Dis 6:24 [CrossRef]
   [Google Scholar]
8. NCCLS 2000 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically . Approved Standard, 5th edn. NCCLS document M7-A5 Wayne, PA: National Committee for Clinical Laboratory Standards;
   [Google Scholar]
9. Paterson D. L., Bonomo R. L. 2005; Extended-spectrum β -lactamases: a clinical update. Clin Microbiol Rev 18:657–686 [CrossRef]
   [Google Scholar]
10. Sader H. S., Castanheira M., Mendes R. E., Toleman M., Walsh T. R., Jones R. N. 2005; Dissemination and diversity of metallo- β -lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int J Antimicrob Agents 25:57–61 [CrossRef]
    [Google Scholar]
11. Shiroto K., Ishii Y., Kimura S., Alba J., Watanabe K., Matsushima Y., Yamaguchi K. 2005; Metallo- β -lactamase IMP-1 in Providencia rettgeri from two different hospitals in Japan. J Med Microbiol 54:1065–1070 [CrossRef]
    [Google Scholar]
12. Thomson K. S., Sanders C. C. 1992; Detection of extended-spectrum β -lactamases in members of the family Enterobacteriaceae : comparison of the double-disk and three-dimensional tests. Antimicrob Agents Chemother 36:1877–1882 [CrossRef]
    [Google Scholar]
13. Walsh T. R., Toleman M. A., Poirel L., Nordmann P. 2005; Metallo- β -lactamases: the quiet before the storm?. Clin Microbiol Rev 18:306–325 [CrossRef]
    [Google Scholar]